Why the study?
Does selective antagonism of angiotensin receptor subtypes (AT1, AT2) alter renal hemodynamics in rats with myocardial infarction?
Does selective antagonism of angiotensin receptor subtypes (AT1, AT2) alter renal hemodynamics in rats with myocardial infarction?
Angiotensin II acts at both AT1 and AT2 receptor sites to modulate renal hemodynamics in rats with reduced cardiac mass post-myocardial infarction.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for dual AT1/AT2 blockade effects on renal hemodynamics post-MI; leaves open translation to human HF.
Rats with congestive heart failure demonstrate striking intrarenal vasoconstriction that contributes to reduced renal excretory function. The importance of specific angiotensin II receptor subtypes (AT1, AT2) for mediating changes in renal hemodynamics was studied in anesthetized rats 1 mo after myocardial infarction (MI) created by coronary artery ligation. AT1 antagonism with losartan alone decreased mean arterial pressure (MAP), total peripheral resistance (TPR), and renal resistance (RR) in control and MI rats to a similar extent without affecting renal blood flow (RBF) or RBF as a percentage of cardiac output (%RBF/CO). In contrast, AT2 antagonism with PD-123319 alone significantly reduced MAP and RR in MI rats without affecting these parameters in control rats. TPR and %RBF/CO were not changed significantly in either group. In contrast, combined AT1- and AT2-receptor inhibition lowered TPR and RR and increased RBF and %RBF/CO, thus the effects of renin or ACE inhibition were mimicked in MI rats. We conclude that angiotensin II acts at both AT1 and AT2 receptor sites in rats with reduced cardiac mass to modulate renal hemodynamics.
No takes yet. Share an insight, caveat, or question.
Mento et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: